Not Medicare Enrolled

Dr. Luis Gonzalez-Mendoza, M.D.

Pediatric Endocrinology · Miami, FL
3100 SW 62ND AVE STE 122, Miami, FL 33155
3056628398
Registered in NPPES since 2006
NPI: 1447324744 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gonzalez-Mendoza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gonzalez-Mendoza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gonzalez-Mendoza

Dr. Luis Gonzalez-Mendoza is a pediatric endocrinology specialist in Miami, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Gonzalez-Mendoza received a total of $11,898 from 44 pharmaceutical and/or device companies across 281 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gonzalez-Mendoza is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $11,898 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$11,898
Total received (2018-2024)
Avg $1,700/year across 7 years
Top 21% in FL for pediatric endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
281
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$491
2023
$696
2022
$1,301
2021
$612
2020
$470
2019
$4,285
2018
$4,043

Payments by company (2024)

Novo Nordisk Inc
$58
ABBVIE INC.
$57
SANOFI-AVENTIS U.S. LLC
$55
BETA BIONICS, INC.
$50
Kyowa Kirin, Inc.
$49
Eton Pharmaceuticals, Inc.
$43
Dexcom, Inc.
$41
Ascendis Pharma Inc
$29
Neurocrine Biosciences, Inc.
$25
Insulet Corporation
$24
Abbott Laboratories
$23
Medtronic, Inc.
$19
PFIZER INC.
$18
Top 3 companies account for 34.5% of 2024 payments
All-time payments by company (2018-2024) ›
Ferring Pharmaceuticals Inc.
$3,396
Medtronic MiniMed, Inc.
$1,451
Janssen Research & Development, LLC
$1,331
Insulet Corporation
$1,010
Novo Nordisk Inc
$544
Tandem Diabetes Care, Inc.
$472
Alexion Pharmaceuticals, Inc.
$314
Lilly USA, LLC
$306
Ascendis Pharma, Inc.
$275
AbbVie, Inc.
$255
ABBVIE INC.
$246
Dexcom, Inc.
$232
Ultragenyx Pharmaceutical Inc.
$202
Ipsen Biopharmaceuticals, Inc
$158
Xeris Pharmaceuticals, Inc.
$145
Becton, Dickinson and Company
$140
LifeScan, Inc.
$139
Eton Pharmaceuticals, Inc.
$136
Amneal Pharmaceuticals LLC
$89
Ascendis Pharma Inc
$85
Abbott Laboratories
$79
LIFESCAN, INC.
$72
SANOFI-AVENTIS U.S. LLC
$72
Kyowa Kirin, Inc.
$69
PFIZER INC.
$65
Zealand Pharma US, Inc.
$61
Arbor Pharmaceuticals, Inc.
$58
Gemini Laboratories, LLC
$54
BETA BIONICS, INC.
$50
BioMarin Pharmaceutical Inc.
$45
TOLMAR Pharmaceuticals, Inc.
$43
Rhythm Pharmaceuticals, Inc.
$39
ARBOR PHARMACEUTICALS, INC.
$36
Medtronic, Inc.
$33
IBSA Pharma Inc.
$28
Neurocrine Biosciences, Inc.
$25
Tolmar, Inc.
$21
AbbVie Inc.
$20
Aegerion Pharmaceuticals, Inc.
$19
Embecta Corp.
$18
GENZYME CORPORATION
$18
VistaPharm, Inc.
$17
Endo Pharmaceuticals Inc.
$15
Azurity Pharmaceuticals, Inc.
$14
Top 3 companies account for 51.9% of all-time payments
Associated products mentioned in payments ›
ALKINDI · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Creon · Crysvita · Dexcom CGM · Dexcom G6 Transmitter · FENSOLVI · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GENOTROPIN · GLYXAMBI · GVOKE PFS · HUMALOG · INCRELEX · INVOKANA · Imcivree · InPen · Increlex · Kanuma · LUPRON DEPOT · Levemir · Lupron Depot · MPS I-DISEASE · MYCARELINK · Macrilen · Minimed 670G System · Minimed Paradigm Revel · Norditropin · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · Omnipod · OneTouch · OneTouch Verio Reflect · SKYTROFA · STRENSIQ · SUPPRELIN LA · Skytrofa · Sogroya · Somatuline Depot · Strensiq · Synthroid · TZIELD · Thyquidity · Tirosint · Tresiba · Triptodur · UNITHROID · VOXZOGO · Victoza · Wegovy · ZEGALOGUE · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric endocrinology specialist in Miami?
Compare pediatric endocrinologists in the Miami area by procedure volume, costs, and industry payment transparency.
Browse pediatric endocrinologists nearby

Geographic Context

Pediatric endocrinologists in nearby ZIP areas
28
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
KERALTY HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gonzalez-Mendoza is a pediatric endocrinology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Gonzalez-Mendoza receive payments from pharmaceutical companies?
Yes. Dr. Gonzalez-Mendoza received a total of $11,898 from 44 companies across 281 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Gonzalez-Mendoza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Endocrinologists in Miami
Browse pediatric endocrinologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Endocrinologists in FL
Pediatric endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Endocrinologists in FL
Which FL pediatric endocrinologists receive the most from drug and device companies.
By company
Ferring Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ferring Pharmaceuticals Inc.
By company
Medtronic MiniMed, Inc. Payments to Doctors
See all physicians who received payments from Medtronic MiniMed, Inc.
By company
Janssen Research & Development, LLC Payments to Doctors
See all physicians who received payments from Janssen Research & Development, LLC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →